Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Dual blockade of the renin–angiotensin–aldosterone system in patients with diabetic nephropathy

Nature Clinical Practice Nephrology volume 3, pages 532–533 (2007)Cite this article

boxed-textJennings DL et al. (2007) Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med 24: 486–493

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lansang MC et al. (2005) ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus. Kidney Int 67: 1033–1037

    Article  CAS  Google Scholar 

  2. Ogawa S et al. (2007) Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy. Hypertens Res 30: 325–334

    Article  CAS  Google Scholar 

  3. Nakao N et al. (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361: 117–124

    Article  CAS  Google Scholar 

  4. Barnett AH et al. (2005) Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351: 1952–1961

    Article  Google Scholar 

  5. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. University of Colorado, Health Sciences Center, Division of Renal Diseases and Hypertension, 4200 East 9th Avenue, C281 BRB, Room 423, Denver, CO 80262, USA yolanda.bogaert@uchsc.edu

Authors and Affiliations

  1. YE Bogaert is an Assistant Professor of Medicine in the Division of Renal Diseases and Hypertension at the University of Colorado, Denver, CO, USA.,

    Yolanda E Bogaert

Authors
  1. Yolanda E Bogaert
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bogaert, Y. Dual blockade of the renin–angiotensin–aldosterone system in patients with diabetic nephropathy. Nat Rev Nephrol 3, 532–533 (2007). https://doi.org/10.1038/ncpneph0599

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0599

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing